Bio-Rad Laboratories (BIO) ROE: History & Chart

Bio-Rad Laboratories, Inc.(BIO)

Medical - Devices · Hercules, CA

$381.09-5.02 (-1.30%)

Delayed quote: Sep 8, 2026, 3:20 PM EDT

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

BIO Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

3.10%

RETURN ON EQUITY (ROE) AVG TTM

2.04%

RETURN ON EQUITY (ROE) AVG 3Y

-5.46%

RETURN ON EQUITY (ROE) AVG 5Y

-4.97%

RETURN ON EQUITY (ROE) AVG 10Y

6.80%

RETURN ON EQUITY (ROE) AVG 15Y

4.99%

RETURN ON EQUITY (ROE) AVG 20Y

6.65%

CURRENT VS TTM AVG

+51.92%

CURRENT VS 3Y AVG

+156.78%

CURRENT VS 5Y AVG

+162.42%

CURRENT VS 10Y AVG

-54.43%

CURRENT VS 15Y AVG

-37.83%

CURRENT VS 20Y AVG

-53.40%

SECTOR MEDIAN · HEALTHCARE

13.25%

median of 83 covered companies

CURRENT VS SECTOR MEDIAN

-76.60%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Bio-Rad Laboratories, Inc. (BIO)	$10.26B	3.10%	2.04%	-5.46%	-4.97%
Molina Healthcare, Inc. (MOH)vs ›	$10.28B	-0.17%	18.91%	22.60%	24.60%
Globus Medical, Inc. (GMED)vs ›	$10.22B	11.23%	7.12%	6.90%	7.16%
Henry Schein, Inc. (HSIC)vs ›	$10.16B	12.77%	11.88%	12.69%	13.50%
The Ensign Group, Inc. (ENSG)vs ›	$10.02B	15.51%	15.81%	15.92%	17.27%
Universal Health Services, Inc. (UHS)vs ›	$10.49B	20.31%	18.80%	15.17%	15.31%
Insulet Corp. (PODD)vs ›	$9.87B	26.39%	25.41%	19.99%	14.02%
Align Technology, Inc. (ALGN)vs ›	$11.11B	9.77%	10.54%	10.84%	19.93%
Tempus AI, Inc. (TEM)vs ›	$11.25B	-57.18%	-651.33%	-315.37%	-198.08%
Bio-Techne Corporation (TECH)vs ›	$11.32B	8.63%	6.23%	8.78%	10.01%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Bio-Rad Laboratories, Inc. (BIO)

$10.26B

3.10%

2.04%

-5.46%

-4.97%

Molina Healthcare, Inc. (MOH)vs ›

$10.28B

-0.17%

18.91%

22.60%

24.60%

Globus Medical, Inc. (GMED)vs ›

$10.22B

11.23%

7.12%

6.90%

7.16%

Henry Schein, Inc. (HSIC)vs ›

$10.16B

12.77%

11.88%

12.69%

13.50%

The Ensign Group, Inc. (ENSG)vs ›

$10.02B

15.51%

15.81%

15.92%

17.27%

Universal Health Services, Inc. (UHS)vs ›

$10.49B

20.31%

18.80%

15.17%

15.31%

Insulet Corp. (PODD)vs ›

$9.87B

26.39%

25.41%

19.99%

14.02%

Align Technology, Inc. (ALGN)vs ›

$11.11B

9.77%

10.54%

10.84%

19.93%

Tempus AI, Inc. (TEM)vs ›

$11.25B

-57.18%

-651.33%

-315.37%

-198.08%

Bio-Techne Corporation (TECH)vs ›

$11.32B

8.63%

6.23%

8.78%

10.01%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The return on equity (ROE) for BIO stock is 3.10%.

Is Bio-Rad Laboratories, Inc.'s return on equity (ROE) high or low?

The return on equity (ROE) of 3.10% is 162% above its 5-year average of -4.97%, around the middle of its 5-year range (-71.36%–43.43%).

What is the TTM average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The TTM average return on equity (ROE) for BIO stock is 2.04%.

What is the 3Y average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The 3Y average return on equity (ROE) for BIO stock is -5.46%.

What is the 5Y average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The 5Y average return on equity (ROE) for BIO stock is -4.97%.

What is the 10Y average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The 10Y average return on equity (ROE) for BIO stock is 6.80%.

What is the 15Y average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The 15Y average return on equity (ROE) for BIO stock is 4.99%.

What is the 20Y average return on equity (ROE) for Bio-Rad Laboratories, Inc. (BIO)?

The 20Y average return on equity (ROE) for BIO stock is 6.65%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	3.10%
2026-03-31	2.46%
2025-12-31	10.20%
2025-09-30	-10.03%
2025-06-30	4.48%
2025-03-31	-32.40%
2024-12-31	-28.07%
2024-09-30	-10.40%
2024-06-30	-19.56%
2024-03-31	-3.56%
2023-12-31	-7.29%
2023-09-30	-1.82%
2023-06-30	-5.02%
2023-03-31	-1.94%
2022-12-31	-37.70%
2022-09-30	-71.36%
2022-06-30	-21.74%
2022-03-31	-0.97%
2021-12-31	31.03%
2021-09-30	43.43%
2021-06-30	34.89%
2021-03-31	38.63%
2020-12-31	38.53%
2020-09-30	39.89%
2020-06-30	26.48%
2020-03-31	25.10%
2019-12-31	30.56%
2019-09-30	7.25%
2019-06-30	16.41%
2019-03-31	11.71%
2018-12-31	8.98%
2018-09-30	25.79%
2018-06-30	22.03%
2018-03-31	16.91%
2017-12-31	3.92%
2017-09-30	0.85%
2017-06-30	0.54%
2017-03-31	1.04%
2016-12-31	1.09%
2016-09-30	3.63%
2016-06-30	3.72%
2016-03-31	4.23%
2015-12-31	4.54%
2015-09-30	4.22%
2015-06-30	4.10%
2015-03-31	4.55%
2014-12-31	4.07%
2014-09-30	3.67%
2014-06-30	2.73%
2014-03-31	2.88%
2013-12-31	3.53%
2013-09-30	4.45%
2013-06-30	6.96%
2013-03-31	7.77%
2012-12-31	8.40%
2012-09-30	9.35%
2012-06-30	9.96%
2012-03-31	9.58%
2011-12-31	10.22%
2011-09-30	11.04%
2011-06-30	10.76%
2011-03-31	11.39%
2010-12-31	12.07%
2010-09-30	10.92%
2010-06-30	11.61%
2010-03-31	11.64%
2009-12-31	11.48%
2009-09-30	8.15%
2009-06-30	7.91%
2009-03-31	9.09%
2008-12-31	8.60%
2008-09-30	10.48%
2008-06-30	9.89%
2008-03-31	8.55%
2007-12-31	9.57%
2007-09-30	10.28%
2007-06-30	10.31%
2007-03-31	11.51%
2006-12-31	12.60%
2006-09-30	12.75%
2006-06-30	12.32%
2006-03-31	11.28%
2005-12-31	12.39%
2005-09-30	13.13%
2005-06-30	11.98%
2005-03-31	12.78%
2004-12-31	11.43%
2004-09-30	12.70%
2004-06-30	13.53%
2004-03-31	13.85%
2003-12-31	15.36%
2003-09-30	15.94%
2003-06-30	17.87%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

3.10%

2026-03-31

2.46%

2025-12-31

10.20%

2025-09-30

-10.03%

2025-06-30

4.48%

2025-03-31

-32.40%

2024-12-31

-28.07%

2024-09-30

-10.40%

2024-06-30

-19.56%

2024-03-31

-3.56%

2023-12-31

-7.29%

2023-09-30

-1.82%

2023-06-30

-5.02%

2023-03-31

-1.94%

2022-12-31

-37.70%

2022-09-30

-71.36%

2022-06-30

-21.74%

2022-03-31

-0.97%

2021-12-31

31.03%

2021-09-30

43.43%

2021-06-30

34.89%

2021-03-31

38.63%

2020-12-31

38.53%

2020-09-30

39.89%

2020-06-30

26.48%

2020-03-31

25.10%

2019-12-31

30.56%

2019-09-30

7.25%

2019-06-30

16.41%

2019-03-31

11.71%

2018-12-31

8.98%

2018-09-30

25.79%

2018-06-30

22.03%

2018-03-31

16.91%

2017-12-31

3.92%

2017-09-30

0.85%

2017-06-30

0.54%

2017-03-31

1.04%

2016-12-31

1.09%

2016-09-30

3.63%

2016-06-30

3.72%

2016-03-31

4.23%

2015-12-31

4.54%

2015-09-30

4.22%

2015-06-30

4.10%

2015-03-31

4.55%

2014-12-31

4.07%

2014-09-30

3.67%

2014-06-30

2.73%

2014-03-31

2.88%

2013-12-31

3.53%

2013-09-30

4.45%

2013-06-30

6.96%

2013-03-31

7.77%

2012-12-31

8.40%

2012-09-30

9.35%

2012-06-30

9.96%

2012-03-31

9.58%

2011-12-31

10.22%

2011-09-30

11.04%

2011-06-30

10.76%

2011-03-31

11.39%

2010-12-31

12.07%

2010-09-30

10.92%

2010-06-30

11.61%

2010-03-31

11.64%

2009-12-31

11.48%

2009-09-30

8.15%

2009-06-30

7.91%

2009-03-31

9.09%

2008-12-31

8.60%

2008-09-30

10.48%

2008-06-30

9.89%

2008-03-31

8.55%

2007-12-31

9.57%

2007-09-30

10.28%

2007-06-30

10.31%

2007-03-31

11.51%

2006-12-31

12.60%

2006-09-30

12.75%

2006-06-30

12.32%

2006-03-31

11.28%

2005-12-31

12.39%

2005-09-30

13.13%

2005-06-30

11.98%

2005-03-31

12.78%

2004-12-31

11.43%

2004-09-30

12.70%

2004-06-30

13.53%

2004-03-31

13.85%

2003-12-31

15.36%

2003-09-30

15.94%

2003-06-30

17.87%

Return on Equity (ROE): 3.10%

BIO Return on Equity (ROE)

BIO Average Return on Equity (ROE) Chart

BIO Current vs Average Return on Equity (ROE) Chart

BIO Return on Equity (ROE) Metrics

BIO Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

BIO Return on Equity (ROE) History

Related Metrics